# Systematic Escalation of diuREtics With Natriuresis in Heart Failure Patients: SERENA Trial

Study · id `cardio:ct-nct04907123` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04907123](<https://clinicaltrials.gov/study/NCT04907123>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04907123

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 198 participants.

## Technical summary

Registry record NCT04907123. Randomized; single masking; primary purpose treatment. Start 2021-10 (anticipated); primary completion 2024-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 198 participants (planned count; ClinicalTrials.gov record NCT04907123, source copy `cardio:ctgov-nct04907123-2021-05-28`, retrieved 2026-10-26)
- Planned start: 2021-10 (anticipated) (ClinicalTrials.gov record NCT04907123, source copy `cardio:ctgov-nct04907123-2021-05-28`, retrieved 2026-10-26)
- Primary completion: 2024-10 (anticipated) (ClinicalTrials.gov record NCT04907123, source copy `cardio:ctgov-nct04907123-2021-05-28`, retrieved 2026-10-26)
- Completion: 2025-01 (anticipated) (ClinicalTrials.gov record NCT04907123, source copy `cardio:ctgov-nct04907123-2021-05-28`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT04907123, source copy `cardio:ctgov-nct04907123-2021-05-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04907123-2021-05-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Systematic Escalation of diuREtics With Natriuresis in Heart Failure Patients: SERENA Trial
- Acronym: SERENA
- Condition: Heart Failure
- Intervention (Other): Intensive sodiuria-guided diuretic treatment
- Intervention (Other): Standard diuretic treatment
- Lead sponsor: University of Turin, Italy
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: University of Turin, Italy (`cardio:org-university-of-turin-italy`)

## Provenance

Content hash: fd82b2f18019d2ebeaa839646a49cf6c06f50397b6a9fc95fd6b0b8652116204
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
